-
Press release - 25/04/2023
Roboticists at the Max Planck Institute for Intelligent Systems in Stuttgart have developed a jellyfish-inspired underwater robot with which they hope one day to collect waste from the bottom of the ocean. The almost noise-free prototype can trap objects underneath its body without physical contact, thereby enabling safe interactions in delicate environments such as coral reefs. Jellyfish-Bot could become a tool for environmental remediation.
https://www.biooekonomie-bw.de/en/articles/pm/jellyfish-robots-could-one-day-clean-worlds-oceans
-
"Programmable" polymer materials - 24/04/2023
It is impossible to imagine medicine without 3D printing, which can be used to make implants or for culturing cells and tissues. It is now possible for 3D objects to be given an added dimension, namely an ability to make simple autonomous movements, by changing their size. Researchers at Heidelberg University have been able to produce microscopically small 4D structures from intelligent polymers that can be tailored to individual requirements.
https://www.gesundheitsindustrie-bw.de/en/article/news/medicine-future-intelligent-4d-polymers-printer
-
-
Press release - 21/04/2023
In collaboration with the project partners CG TEC, Cordenka, ElringKlinger, Fiber Engineering and Technikum Laubholz, the DITF are developing a new fiber composite material (CELLUN) with reinforcing fibers made of cellulose. The matrix of the material is a thermoplastic cellulose derivative. CELLUN made from renewable biopolymers enables the replacement of glass or carbon fibers in the production of industrial molded parts.
https://www.biooekonomie-bw.de/en/articles/pm/cellun-fiber-composite-made-biopolymers
-
-
-
-
-
-
-
-
Press release - 30/03/2023
Composite materials provide stability in aircraft parts, sports equipment, and everyday household items. However, most of these materials have a poor carbon footprint and are not naturally degradable. A more sustainable alternative has been developed by a team from the University of Stuttgart. This completely bio-based composite material is made of flax fibers and the biopolymer chitosan.
https://www.biooekonomie-bw.de/en/articles/pm/green-composite-material-made-flax-and-chitosan
-
Inovedis GmbH’s innovative implant - 28/03/2023
The treatment of shoulder injuries such as rotator cuff tears is one of the most common orthopaedic interventions. It is therefore quite surprising that the surgical procedure has not changed much for decades - although it is relatively complicated. The start-up Inovedis has now developed a completely new surgical technique based on an implant that can be performed simply, safely, quickly and cost-effectively with minimal stress for patients.
https://www.gesundheitsindustrie-bw.de/en/article/news/next-generation-minimally-invasive-shoulder-surgery
-
-
-
Development of anti-tumour agents - 20/03/2023
Cancer cells have different mechanisms to help them escape destruction by the immune system. Solid tumours, for example, are often surrounded by a protective layer of lactate, which has a strong immunosuppressive effect. WMT AG from Heidelberg is developing small drug molecules that reduce lactate production and thus make cancer cells vulnerable to immune system attacks.
https://www.gesundheitsindustrie-bw.de/en/article/news/targeting-protective-shield-cancers
-
-
Residual materials with potential - 16/03/2023
The objective of the PeePower™ BUGA 2023 collaborative research project is to produce green hydrogen and platform chemicals from wastewater. This fits in nicely with BUGA 2023’s (German National Garden Show) four major themes, namely, climate, energy, environment and food security.
https://www.biooekonomie-bw.de/en/articles/pm/peepower-energy-urine
-
-
-
-
Expert interview - 08/03/2023
Access to capital remains one of the biggest challenges in the life sciences sector. Over the last two years, the Baden-Württemberg Center for Academic Drug Discovery (BWCAD2) has successfully implemented a model of cooperation between academic drug research and industry for the development and validation of therapeutic concepts. Dr. Barbara Jonischkeit spoke with the initiator and leading figure behind the BWCAD2 project, Prof. Dr. Stefan Laufer
https://www.gesundheitsindustrie-bw.de/en/article/news/how-do-new-active-substances-university-research-reach-patients
-
-
Website address: https://www.biooekonomie-bw.de/en/search